BNR
NASDAQStockBurning Rock Biotech Limited
$22.85-0.61 (-2.60%)
52-Week Range
$2.32
$41.06
Key Stats
Market Cap
N/A
P/E Ratio
N/A
Dividend Yield
N/A
Beta
1.45
Volume
3.7K
Avg Volume
24.4K
Performance
1M
-26.29%
3M
+45.08%
6M
+162.34%
YTD
+16.11%
1Y
+323.93%
3Y
-18.39%
5Y
-91.04%
Price Chart
ETF Exposure
BNR is held by 14 ETFs
| ETF | Fund Name | Weight |
|---|---|---|
| DINT | Davis Select International ETF | 1.48% |
| CHNA | Loncar China BioPharma ETF | 1.29% |
| RBIN | Nationwide Risk-Based International Equity ETF | 0.34% |
| PQIN | PGIM Quant Solutions Strategic Alpha International Equity ETF | 0.25% |
| HFXE | IQ 50 Percent Hedged FTSE Europe ETF | 0.20% |
| PXUS | Principal International Adaptive Multi-Factor ETF | 0.11% |
| EHLS | Even Herd Long Short ETF | 0.05% |
| FNDF | Schwab Fundamental International Large Company Index ETF | 0.04% |
| HFXI | NYLI FTSE International Equity Currency Neutral ETF | 0.04% |
| NTSI | WisdomTree International Efficient Core Fund | 0.04% |
| TACN | T. Rowe Price Active Core International Equity ETF | 0.03% |
| SCHF | Schwab International Equity ETF | 0.02% |
| TLTD | FlexShares Morningstar Developed Markets ex-US Factor Tilt Index Fund | 0.01% |
| MFDX | PIMCO RAFI Dynamic Multi-Factor International Equity ETF | 0.01% |
About BNR ETF Exposure
Burning Rock Biotech Limited (BNR) is held by 14 exchange-traded funds, making it one of the stocks with significant ETF exposure. The stock currently trades at $22.85. Investors can gain exposure to BNR through a variety of ETFs with different expense ratios, investment strategies, and portfolio weightings. The table above shows all ETFs that currently hold BNR, sorted by portfolio weight.